Cardiff Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:XE7C Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Dec 24	Buy€35,047	James Levine	Individual	7,716	€5.17
12 Dec 24	Buy€32,629	Renee Tannenbaum	Individual	10,000	€3.26
11 Dec 24	Buy€896,668	Gary Pace	Individual	361,615	€2.48

Insider Trading Volume

Insider Buying: XE7C insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of XE7C?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,343,911	2.02%
Public Companies	2,411,575	3.63%
Hedge Funds	5,384,616	8.09%
Institutions	13,105,931	19.7%
General Public	44,278,149	66.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 48.9%.

Top Shareholders

Top 25 shareholders own 30.93% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.09%	Commodore Capital LP	5,384,616	€21.6m	0%	1.71%
4.27%	BlackRock, Inc.	2,840,909	€11.4m	3.85%	no data
3.63%	Pfizer Inc.	2,411,575	€9.7m	0%	no data
3.26%	The Vanguard Group, Inc.	2,171,444	€8.7m	1.64%	no data
1.59%	Gary Pace	1,059,376	€4.2m	51.8%	no data
1.4%	Geode Capital Management, LLC	928,232	€3.7m	1.93%	no data
1.25%	State Street Global Advisors, Inc.	832,652	€3.3m	3.43%	no data
1%	MAI Capital Management, LLC	663,363	€2.7m	0.69%	0.03%
0.91%	Renaissance Technologies LLC	602,384	€2.4m	282%	no data
0.74%	Morgan Stanley, Investment Banking and Brokerage Investments	494,943	€2.0m	-2.21%	no data
0.57%	GSA Capital Partners LLP	380,070	€1.5m	104%	0.13%
0.51%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	337,766	€1.4m	536%	no data
0.5%	Two Sigma Advisers, LP	331,200	€1.3m	60%	no data
0.47%	Northern Trust Global Investments	309,603	€1.2m	215%	no data
0.43%	BNY Asset Management	288,615	€1.2m	68.7%	no data
0.37%	William Blair Investment Management, LLC	247,078	€988.9k	8.54%	no data
0.35%	Acorn Bioventures	235,096	€940.9k	0%	1.98%
0.28%	Two Sigma Investments, LP	184,573	€738.7k	-15.6%	no data
0.23%	Millennium Management LLC	152,685	€611.1k	-36.3%	no data
0.21%	Marshall Wace LLP	143,026	€572.4k	-52.1%	no data
0.21%	Avestar Capital, LLC	140,469	€562.2k	0%	0.06%
0.18%	XTX Holdings Limited, Asset Management Arm	120,384	€481.8k	44.3%	0.04%
0.17%	Lale White	113,788	€455.4k	0%	no data
0.15%	Charles Schwab Investment Management, Inc.	101,664	€406.9k	-16.2%	no data
0.15%	Callan Capital, LLC	101,575	€406.5k	11.1%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 15:51
End of Day Share Price	2025/02/12 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cardiff Oncology, Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sung Ji Nam	Avondale Partners
Bryan Brokmeier	Cantor Fitzgerald & Co.
Gum-Ming Lowe	Craig-Hallum Capital Group LLC